Legislators urge investigation into cost of insulin
You might recall that RxRights initiated a campaign last year regarding the skyrocketing price of insulin, based on your feedback. We enlisted your help to pressure drug makers and we’ve long been appealing to legislators. We’re pleased to see these efforts have been fruitful. The insulin issue is finally gaining traction with legislators and the media!
Senator Bernie Sanders (I-VT) and Representative Elijah Cummings (D-MD) sent a letter Thursday calling on the Justice Department and Federal Trade Commission to investigate potential anticompetitive conduct among the few pharmaceutical companies manufacturing medication to treat diabetes.
The letter cites a Bloomberg report regarding apparent tandem price increases in insulin made by the three major insulin manufacturers, Sanofi and Novo Nordisk and Eli Lilly.
The report shows Sanofi and Novo Nordisk raised prices for competing vials of insulin, Lantus and Levemir, by 16.1 percent within one day of other in May of 2014. Thirteen other instances of simultaneous price hikes between these two drugs were found since 2009. Eli Lilly’s Humalog and Novo Nordisk’s Novolog had several instances of concurrent price increases as well.
We can’t let drug companies get away with this! Eli Lilly has already been fined by Mexico for colluding on prices.
Will you help us make a difference during National Diabetes Awareness month? We’re gathering personal stories from Americans affected by the rising price of insulin for Senator Sanders’ office. Click here to share your story and/or pass this email on to a friend or family member with a story to share.
If we keep the pressure on, we’re bound to see results!